Fiche publication
Date publication
juin 2026
Journal
Nature communications
Auteurs
Membres identifiés du Cancéropôle Est :
Pr CHENARD Marie-Pierre
,
Pr KURTZ Jean-Emmanuel
,
Pr MALOUF Gabriel
,
Dr HERVIEU Alice
,
Dr CHARON-BARRA Céline
,
Dr GANTZER Justine
Tous les auteurs :
Gantzer J, Lu X, Charon-Barra C, Vinson C, Weingertner N, Fattori A, Chenard MP, Plassard D, Vicaire S, Le Loarer F, Toulmonde M, Karanian M, Brahmi M, Ngo C, Le Cesne A, Hervieu A, Mescam-Mancini L, Bertucci F, Beaujot J, Ryckewaert T, Rochaix P, Valentin T, Macagno N, Duffaud F, Tallegas M, Chetaille B, Valo I, Bompas E, Lae M, Delalande F, Llamas-Gutierrez F, Rioux-Leclercq N, Blay JY, Kurtz JE, Malouf GG
Lien Pubmed
Résumé
Perivascular epithelioid cell neoplasms (PEComas) are ultra-rare mesenchymal tumors lacking a molecular classification to guide therapy. Here we perform comprehensive multi-omic profiling of an unselected PEComa cohort. We identify frequent MITF rearrangements involving actin gene partners (ACTA2, ACTG1 and ACTB). Anatomical stratification reveals cyclin-dependent kinase module mutations in gynecologic tumors, whereas soft tissue, gastrointestinal, and pelvic tumors lacked mTOR pathway alterations but are enriched for TFE3/MITF rearrangements. Transcriptomic analysis defines four subtypes with distinct lineage programs-melanocytic, mesenchymal, or adipogenic-as well as unique mutational patterns and clinical behaviors. Notably, an aggressive stem-like subtype enriched for TP53/RB1 mutations exhibits high proliferation, activation of embryonic and Hedgehog signaling, immune infiltration, and resistance to mTOR inhibitors, but potential responsiveness to immunotherapy. Single-nucleus RNA sequencing reveals intra-tumoral heterogeneity within this subtype, including divergent inflammatory states. Together, these findings establish a molecular classification framework and identify actionable vulnerabilities in PEComa.
Référence
Nat Commun. 2026 06 23;:
